AAAAAA

   
Results: 1-21 |
Results: 21
New targets for tumor radiosensitization - Introduction
Authors: Kinsella, TJ McGinn, CJ
Citation: Tj. Kinsella et Cj. Mcginn, New targets for tumor radiosensitization - Introduction, SEM RAD ONC, 11(4), 2001, pp. 269-269
Targeting DNA mismatch repair for radiosensitization
Authors: Berry, SE Kinsella, TJ
Citation: Se. Berry et Tj. Kinsella, Targeting DNA mismatch repair for radiosensitization, SEM RAD ONC, 11(4), 2001, pp. 300-315
When X-ray-inducible proteins meet DNA double strand break repair
Authors: Leskov, KS Criswell, T Antonio, S Li, J Yang, CR Kinsella, TJ Boothman, DA
Citation: Ks. Leskov et al., When X-ray-inducible proteins meet DNA double strand break repair, SEM RAD ONC, 11(4), 2001, pp. 352-372
Methoxyamine potentiates DNA single strand breaks and double strand breaksinduced by temozolomide in colon cancer cells
Authors: Taverna, P Liu, LL Hwang, HS Hanson, AJ Kinsella, TJ Gerson, SL
Citation: P. Taverna et al., Methoxyamine potentiates DNA single strand breaks and double strand breaksinduced by temozolomide in colon cancer cells, MUT R-DNA R, 485(4), 2001, pp. 269-281
Radioimmunoguided imaging of prostate cancer foci with histopathological correlation
Authors: Ellis, RJ Kim, EY Conant, R Sodee, DB Spirnak, JP Dinchman, KH Beddar, S Wessels, B Resnick, MI Kinsella, TJ
Citation: Rj. Ellis et al., Radioimmunoguided imaging of prostate cancer foci with histopathological correlation, INT J RAD O, 49(5), 2001, pp. 1281-1286
A miniature "scintillator-fiberoptic-PMT" detector system for the dosimetry of small fields in stereotactic radiosurgery
Authors: Beddar, AS Kinsella, TJ Ikhlef, A Sibata, CH
Citation: As. Beddar et al., A miniature "scintillator-fiberoptic-PMT" detector system for the dosimetry of small fields in stereotactic radiosurgery, IEEE NUCL S, 48(3), 2001, pp. 924-928
Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation
Authors: Yan, T Schupp, JE Hwang, HS Wagner, MW Berry, SE Strickfaden, S Veigl, ML Sedwick, WD Boothman, DA Kinsella, TJ
Citation: T. Yan et al., Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation, CANCER RES, 61(22), 2001, pp. 8290-8297
Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediatedcell death and cell cycle responses
Authors: Meyers, M Wagner, MW Hwang, HS Kinsella, TJ Boothman, DA
Citation: M. Meyers et al., Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediatedcell death and cell cycle responses, CANCER RES, 61(13), 2001, pp. 5193-5201
Cell cycle regulation of the G(0)/G(1) transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines
Authors: McGinn, CJ Pestalozzi, BC Drake, JC Glennon, MC Kunugi, K Otterson, G Allegra, CJ Johnston, PG Kinsella, TJ
Citation: Cj. Mcginn et al., Cell cycle regulation of the G(0)/G(1) transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines, CANCER J, 6(4), 2000, pp. 234-242
Preclinical study of the systemic toxicity and pharmacokinetics of 5-iodo-2-deoxypyrimidinone-2 '-deoxyribose as a radiosensitizing prodrug in two, non-rodent animal species: Implications for phase I study design
Authors: Kinsella, TJ Schupp, JE Davis, TW Berry, SE Hwang, HS Warren, K Balis, F Barnett, J Sands, H
Citation: Tj. Kinsella et al., Preclinical study of the systemic toxicity and pharmacokinetics of 5-iodo-2-deoxypyrimidinone-2 '-deoxyribose as a radiosensitizing prodrug in two, non-rodent animal species: Implications for phase I study design, CLIN CANC R, 6(9), 2000, pp. 3670-3679
Preclinical toxicity and efficacy study of a 14-day schedule of oral 5-iodo-2-pyrimidinone-2 '-deoxyribose as a prodrug for 5-iodo-2 '-deoxyuridine radiosensitization in U251 human glioblastoma xenografts
Authors: Kinsella, TJ Vielhuber, KA Kunugi, KA Schupp, J Davis, TW Sands, H
Citation: Tj. Kinsella et al., Preclinical toxicity and efficacy study of a 14-day schedule of oral 5-iodo-2-pyrimidinone-2 '-deoxyribose as a prodrug for 5-iodo-2 '-deoxyuridine radiosensitization in U251 human glioblastoma xenografts, CLIN CANC R, 6(4), 2000, pp. 1468-1475
Alternative techniques of intraoperative radiotherapy
Authors: Ellis, RJ Nag, S Kinsella, TJ
Citation: Rj. Ellis et al., Alternative techniques of intraoperative radiotherapy, EUR J SUR O, 26, 2000, pp. S25-S27
Feasibility and acute toxicities of radioimmunoguided prostate brachytherapy
Authors: Ellis, RJ Sodee, DB Spirnak, JP Dinchman, KH O'Leary, AW Samuels, MA Resnick, MI Kinsella, TJ
Citation: Rj. Ellis et al., Feasibility and acute toxicities of radioimmunoguided prostate brachytherapy, INT J RAD O, 48(3), 2000, pp. 683-687
Photodynamic therapy: a new concept in medical treatment
Authors: Sibata, CH Colussi, VC Oleinick, NL Kinsella, TJ
Citation: Ch. Sibata et al., Photodynamic therapy: a new concept in medical treatment, BRAZ J MED, 33(8), 2000, pp. 869-880
Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signalscell death
Authors: Yang, CR Leskov, K Hosley-Eberlein, K Criswell, T Pink, JJ Kinsella, TJ Boothman, DA
Citation: Cr. Yang et al., Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signalscell death, P NAS US, 97(11), 2000, pp. 5907-5912
Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine
Authors: Berry, SE Davis, TW Schupp, JE Hwang, HS de Wind, N Kinsella, TJ
Citation: Se. Berry et al., Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine, CANCER RES, 60(20), 2000, pp. 5773-5780
Radiosensitivity of thymidylate synthase-deficient human tumor cells is affected by progression through the G(1) restriction point into S-phase: Implications for fluoropyrimidine radiosensitization
Authors: Hwang, HS Davis, TW Houghton, JA Kinsella, TJ
Citation: Hs. Hwang et al., Radiosensitivity of thymidylate synthase-deficient human tumor cells is affected by progression through the G(1) restriction point into S-phase: Implications for fluoropyrimidine radiosensitization, CANCER RES, 60(1), 2000, pp. 92-100
Studies of intraoperative radiotherapy in carcinoma of the pancreas
Authors: Sindelar, WF Kinsella, TJ
Citation: Wf. Sindelar et Tj. Kinsella, Studies of intraoperative radiotherapy in carcinoma of the pancreas, ANN ONCOL, 10, 1999, pp. 226-230
Isolation of Ku70-binding proteins (KUBs)
Authors: Yang, CR Yeh, SY Leskov, K Odegaard, E Hsu, HL Chang, CS Kinsella, TJ Chen, DJ Boothman, DA
Citation: Cr. Yang et al., Isolation of Ku70-binding proteins (KUBs), NUCL ACID R, 27(10), 1999, pp. 2165-2174
Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity
Authors: Mineishi, S Longo, WL Atkinson, ME Smith, EP Hamielec, M Wiersma, SR Kinsella, TJ Schuening, FG
Citation: S. Mineishi et al., Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity, BONE MAR TR, 23(12), 1999, pp. 1217-1222
The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells
Authors: Berry, SE Garces, C Hwang, HS Kunugi, K Meyers, M Davis, TW Boothman, DA Kinsella, TJ
Citation: Se. Berry et al., The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells, CANCER RES, 59(8), 1999, pp. 1840-1845
Risultati: 1-21 |